249 related articles for article (PubMed ID: 9300036)
1. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
2. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.
Taylor JP; Pomerantz R; Bagasra O; Chowdhury M; Rappaport J; Khalili K; Amini S
EMBO J; 1992 Sep; 11(9):3395-403. PubMed ID: 1505523
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
4. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe.
Toyama R; Bende SM; Dhar R
Nucleic Acids Res; 1992 May; 20(10):2591-6. PubMed ID: 1598218
[TBL] [Abstract][Full Text] [Related]
6. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line.
Remenick J; Radonovich MF; Brady JN
J Virol; 1991 Oct; 65(10):5641-6. PubMed ID: 1654461
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps.
Jeang KT; Berkhout B
J Biol Chem; 1992 Sep; 267(25):17891-9. PubMed ID: 1517225
[TBL] [Abstract][Full Text] [Related]
9. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
Graham GJ; Maio JJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
[TBL] [Abstract][Full Text] [Related]
10. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
Berkhout B; Jeang KT
J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.
Kato H; Sumimoto H; Pognonec P; Chen CH; Rosen CA; Roeder RG
Genes Dev; 1992 Apr; 6(4):655-66. PubMed ID: 1559613
[TBL] [Abstract][Full Text] [Related]
12. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.
Zhu Y; Pe'ery T; Peng J; Ramanathan Y; Marshall N; Marshall T; Amendt B; Mathews MB; Price DH
Genes Dev; 1997 Oct; 11(20):2622-32. PubMed ID: 9334325
[TBL] [Abstract][Full Text] [Related]
13. The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation.
Browning C; Hilfinger JM; Rainier S; Lin V; Hedderwick S; Smith M; Markovitz DM
J Virol; 1997 Oct; 71(10):8048-55. PubMed ID: 9311903
[TBL] [Abstract][Full Text] [Related]
14. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.
Garber ME; Wei P; KewalRamani VN; Mayall TP; Herrmann CH; Rice AP; Littman DR; Jones KA
Genes Dev; 1998 Nov; 12(22):3512-27. PubMed ID: 9832504
[TBL] [Abstract][Full Text] [Related]
15. TAR-independent replication of human immunodeficiency virus type 1 in glial cells.
Bagasra O; Khalili K; Seshamma T; Taylor JP; Pomerantz RJ
J Virol; 1992 Dec; 66(12):7522-8. PubMed ID: 1433528
[TBL] [Abstract][Full Text] [Related]
16. Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel1 protein requires a specific DNA sequence.
Lee AH; Lee KJ; Kim S; Sung YC
J Virol; 1992 May; 66(5):3236-40. PubMed ID: 1313928
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro.
Bohan CA; Kashanchi F; Ensoli B; Buonaguro L; Boris-Lawrie KA; Brady JN
Gene Expr; 1992; 2(4):391-407. PubMed ID: 1282057
[TBL] [Abstract][Full Text] [Related]
18. Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription.
Liu J; Perkins ND; Schmid RM; Nabel GJ
J Virol; 1992 Jun; 66(6):3883-7. PubMed ID: 1583734
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.
Hammarskjöld ML; Simurda MC
J Virol; 1992 Nov; 66(11):6496-501. PubMed ID: 1404600
[TBL] [Abstract][Full Text] [Related]
20. Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery.
Sakaguchi M; Zenzie-Gregory B; Groopman JE; Smale ST; Kim SY
J Virol; 1991 Oct; 65(10):5448-56. PubMed ID: 1895393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
